FIELD: medicine.
SUBSTANCE: developed agent contains trophoblastic β-1-glycoprotein (TBG), immunoglobulin (Ig) and additionally contains tetrapeptide H-Tyr-X-Y-Glu-OH, wherein X - Gln and/or Glu, Y - Cys (acm) and/or Cys.
EFFECT: effective treatment of autoimmune diseases by single doses containing TBG 1 mg, Ig 19 mg and tetrapeptide 20 mg.
6 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING IMMUNOREGULATORY PROPERTY AND ITS USING IN TREATMENT OF AUTOIMMUNE DISEASES | 2006 |
|
RU2303995C1 |
PEPTIDE COMPOSITION POSSESSING IMMUNOREGULATORY PROPERTY | 2004 |
|
RU2266297C1 |
PEPTIDE COMPOSITION ELICITING IMMUNITY REGULATING PROPERTY | 2003 |
|
RU2244719C1 |
PEPTIDE WITH IMMUNOREGULATING PROPERTY AND COMPOSITION BASED ON THEREOF | 2002 |
|
RU2210382C1 |
AGENT FOR TREATMENT OF AUTOIMMUNE DISEASES WITH SUPPRESSOR IMMUNODEFICIENCY AND A METHOD OF AUTOIMMUNE DISEASES TREATMENT | 1994 |
|
RU2056852C1 |
METHOD OF TREATING RHEUMATOID ARTHRITIS | 0 |
|
SU1816457A1 |
METHOD OD ARTHRITIS TREATMENT | 0 |
|
SU1819616A1 |
DRUG PREPARATION POSSESSING IMMUNOREGULATORY PROPERTY FOR TREATING IMMUNE DISEASES | 2012 |
|
RU2504401C2 |
METHOD OF RHEUMATIC ARTHRITIS TREATMENT | 0 |
|
SU1752414A1 |
METHOD FOR PRODUCTION OF POLYCLONAL T-CELL VACCINE USEFUL IN TREATMENT OF IMMUNOLOGICAL DISORDERS | 2004 |
|
RU2277422C2 |
Authors
Dates
2014-09-10—Published
2013-09-25—Filed